Legend Biotech (LEGN) Invested Capital (2019 - 2025)

Legend Biotech has reported Invested Capital for 7 years, with the latest figure at $1.0 billion in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital fell 22.35% year-over-year to $1.0 billion; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (down 22.35% YoY), and the FY2025 full-year result was $1.0 billion, down 22.35% from the prior year.
• Invested Capital for Q4 2025 stood at $1.0 billion, down from $1.0 billion in the prior quarter.
• The five-year high for Invested Capital was $1.5 billion in Q4 2023, with the low at $206451.0 in Q1 2021.
• Historically, Invested Capital has averaged $945.9 million across 5 years, with a median of $1.0 billion in 2025.
• Annual changes were most pronounced in 2022 — Invested Capital soared 358900.44% — and 2025, when it retreated 22.35%.
• Legend Biotech's Invested Capital stood at $878.7 million in 2021, then surged by 30.11% to $1.1 billion in 2022, then soared by 31.32% to $1.5 billion in 2023, then retreated by 14.04% to $1.3 billion in 2024, then dropped by 22.35% to $1.0 billion in 2025.
• The last three Invested Capital figures came in at $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.